Achilles Therapeutics Plc Stock Market Value
| ACHL Stock | USD 0.78 0.01 1.27% |
| Symbol | Achilles |
Is Achilles Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Achilles Therapeutics. If investors know Achilles will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Achilles Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Achilles Therapeutics PLC is measured differently than its book value, which is the value of Achilles that is recorded on the company's balance sheet. Investors also form their own opinion of Achilles Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Achilles Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Achilles Therapeutics' market value can be influenced by many factors that don't directly affect Achilles Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Achilles Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Achilles Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Achilles Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Achilles Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Achilles Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Achilles Therapeutics.
| 01/25/2024 |
| 04/24/2024 |
If you would invest 0.00 in Achilles Therapeutics on January 25, 2024 and sell it all today you would earn a total of 0.00 from holding Achilles Therapeutics PLC or generate 0.0% return on investment in Achilles Therapeutics over 90 days. Achilles Therapeutics is related to or competes with Assembly Biosciences, Spero Therapeutics, Instil Bio, Nuvation Bio, CytomX Therapeutics, and NextCure. Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapi... More
Achilles Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Achilles Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Achilles Therapeutics PLC upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 38.89 | |||
| Value At Risk | (9.02) | |||
| Potential Upside | 9.56 |
Achilles Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Achilles Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Achilles Therapeutics' standard deviation. In reality, there are many statistical measures that can use Achilles Therapeutics historical prices to predict the future Achilles Therapeutics' volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.15) | |||
| Total Risk Alpha | (0.21) | |||
| Treynor Ratio | (3.40) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Achilles Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Achilles Therapeutics PLC Backtested Returns
Achilles Therapeutics PLC secures Sharpe Ratio (or Efficiency) of -0.0307, which signifies that the company had a -0.0307% return per unit of standard deviation over the last 24 months. Achilles Therapeutics PLC exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Achilles Therapeutics' mean deviation of 3.79, and Risk Adjusted Performance of (0.02) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.0442, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Achilles Therapeutics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Achilles Therapeutics is expected to be smaller as well. Achilles Therapeutics PLC has an expected return of -0.13%. Please make sure to confirm Achilles Therapeutics PLC total risk alpha and the relationship between the potential upside and market facilitation index , to decide if Achilles Therapeutics PLC performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.87 |
Excellent reverse predictability
Achilles Therapeutics PLC has excellent reverse predictability. Overlapping area represents the amount of predictability between Achilles Therapeutics time series from 25th of January 2024 to 10th of March 2024 and 10th of March 2024 to 24th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Achilles Therapeutics PLC price movement. The serial correlation of -0.87 indicates that approximately 87.0% of current Achilles Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.87 | |
| Spearman Rank Test | -0.67 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Achilles Therapeutics PLC lagged returns against current returns
Autocorrelation, which is Achilles Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Achilles Therapeutics' stock expected returns. We can calculate the autocorrelation of Achilles Therapeutics returns to help us make a trade decision. For example, suppose you find that Achilles Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Achilles Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Achilles Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Achilles Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Achilles Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Achilles Therapeutics Lagged Returns
When evaluating Achilles Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Achilles Therapeutics stock have on its future price. Achilles Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Achilles Therapeutics autocorrelation shows the relationship between Achilles Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Achilles Therapeutics PLC.
Regressed Prices |
| Timeline |
Pair Trading with Achilles Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Achilles Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Achilles Therapeutics will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Achilles Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Achilles Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Achilles Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Achilles Therapeutics PLC to buy it.
The correlation of Achilles Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Achilles Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Achilles Therapeutics PLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Achilles Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Achilles Therapeutics Correlation, Achilles Therapeutics Volatility and Achilles Therapeutics Alpha and Beta module to complement your research on Achilles Therapeutics. Note that the Achilles Therapeutics PLC information on this page should be used as a complementary analysis to other Achilles Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Achilles Stock analysis
When running Achilles Therapeutics' price analysis, check to measure Achilles Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Achilles Therapeutics is operating at the current time. Most of Achilles Therapeutics' value examination focuses on studying past and present price action to predict the probability of Achilles Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Achilles Therapeutics' price. Additionally, you may evaluate how the addition of Achilles Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Global Correlations Find global opportunities by holding instruments from different markets |
Achilles Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.